Physics Professor Srinivas Sridhar has received a $1.15 million grant titled “CaNCURE: Cancer Nanomedicine Co-ops for Undergraduate Research Experiences” funded by the National Cancer Institute and the National Institutes of Health. This 5-year grant is a collaboration between Northeastern University and Dana-Farber/Harvard Cancer Center.

The CaNCURE program aims to train the next generation of scientists, technologists, and physicians skilled in research at the interface of nanotechnology, biology, and medicine.

Northeastern is a world-leader in practice-oriented undergraduate education.  CaNCURE combines Northeastern’s co-op model with the extensive research infrastructure at Northeastern and the Dana Farber/ Harvard Cancer Center to create a first-of-its-kind experiential training program specialized in cancer nanomedicine.

“CaNCURE is a unique new program that will create a pipeline for the next generation of cancer nanomedicine scientists and clinicians.  The program heralds a new dimension in the collaboration between Northeastern University and Dana Farber/Harvard Cancer Center,” said Sridhar.

A total of 75 students will be supported over a 5-year period to be trained in cancer nanomedicine research in the laboratories of 35 outstanding mentors at Dana Farber/Harvard Cancer Center and Northeastern. The program provides a hands-on research experience and one-on-one mentoring by leading researchers in cancer nanomedicine. Specialized workshops, weekly seminars, and continuing education activities round out each trainee’s research experience.